The FDA is tightening requirements on accelerated approvals in oncology. Have biotechs the most to lose?
Lifescience Dynamics publications include posters, presentation decks and white papers. All our publications are thoroughly researched and authoritative materials that discuss the impacts of a particular technology, product or policy to its relevant healthcare contexts.
Staying ahead of the curve in the emerging RNA therapeutics space
Accelerated COVID-19 vaccine development – A testament to scientific advancement and institutional collaborations
China’s policy overhauls: What does this mean for pharmaceutical approvals?